Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	43.25	58.18	61.69	165.75	84.77	62.44
Short-Term Investments	397.79	508.68	388.56	387.13	276.82	336.09
Cash & Cash Equivalents	441.04	566.85	450.25	552.88	361.59	398.52
Cash Growth	-21.45%	25.90%	-18.56%	52.90%	-9.27%	-15.48%
Receivables	22.73	21.18	16.65	15.91	15.93	18.05
Inventory	42.31	40.9	4.52	7.31	7.61	6.08
Other Current Assets	-25.01	-12.16	15.02	6.72	25.29	6.41
Total Current Assets	481.08	616.78	486.44	582.83	410.41	429.06
Property, Plant & Equipment	24.21	25.54	30.05	34.3	35.09	2.89
Goodwill and Intangibles	101.18	104.44	97.07	148.44	154.13	158.14
Other Long-Term Assets	57.08	42.16	59.03	11.07	7.81	14.71
Total Long-Term Assets	182.47	172.14	186.15	193.81	197.03	175.74
Total Assets	663.55	788.91	672.59	776.63	607.44	604.8
Accounts Payable	16.73	41.68	17.29	15.14	12.13	26.61
Deferred Revenue	7.35	8.93	22.91	36.65	0	0
Current Debt	5.04	4.91	4.43	3.91	0.36	0
Other Current Liabilities	144.12	122.39	97.53	68.39	80.17	68.84
Total Current Liabilities	173.23	177.91	142.16	124.09	92.66	95.45
Long-Term Debt	398.98	399.88	403.06	258.08	243.68	204.86
Other Long-Term Liabilities	17.27	10.32	84.52	92.36	59.89	83.29
Total Long-Term Liabilities	416.25	410.2	487.57	350.43	303.57	288.16
Total Liabilities	589.48	588.1	629.73	474.52	396.23	383.6
Total Debt	404.02	404.78	407.49	261.99	244.03	204.86
Debt Growth	-0.70%	-0.66%	55.54%	7.36%	19.12%	-5.83%
Retained Earnings	-1,261.68	-1,125.62	-1,014.22	-765.97	-585.88	-416.44
Comprehensive Income	-1.89	-1.46	-2.91	-0.56	-0.9	0.73
Shareholders' Equity	74.07	200.81	42.85	302.11	211.21	221.2
Net Cash / Debt	37.03	162.07	42.76	290.9	117.56	193.66
Net Cash / Debt Growth	-76.06%	279.04%	-85.30%	147.45%	-39.30%	-23.75%
Net Cash Per Share	0.48	2.18	0.67	4.86	2.47	4.57
Working Capital	307.85	438.87	344.27	458.74	317.75	333.62
Book Value Per Share	0.96	2.70	0.67	5.05	4.44	5.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).